Journal of neuro-oncology 146(3) 469-475 2020年2月 [査読有り]
PURPOSE: Glioblastoma is an aggressive central nervous system tumor with a 5-year survival rate of < 10%. The standard therapy for glioblastoma is maximal safe resection, followed by radiation therapy and chemotherapy with temozolomide. New approa...
Hasegawa M   Hatayama T   Kondo A   Nagahiro S   Fujimaki T   Amagasaki K   Arita K   Date I   Fujii Y   Goto T   Hanaya R   Higuchi Y   Hongo K   Inoue T   Kasuya H   Kayama T   Kawashima M   Kohmura E   Maehara T   Matsushima T   Mizobuchi Y   Morita A   Nishizawa S   Noro S   Saito S   Shimano H   Shirane R   Takeshima H   Tanaka Y   Tanabe H   Toda H   Yamakami I   Nishiyama Y   Ohba S   Hirose Y   Suzuki T   
Kuwahara K   Ohba S   Nakae S   Hattori N   Pareira ES   Yamada S   Sasaki H   Abe M   Hasegawa M   Hirose Y